EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma

Weidi Wang, Tianyi Chen, Haoyu Wang, Jiayuan Zhao, Chen Yang, Yuxiao Wu, Yujia Kong, Dan Wang, Yuan Li, Junjun Yang, Yang Xiang

Frontiers in Immunology · 2026

DOI: 10.3389/fimmu.2026.1817862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Weidi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Women's Health and Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Me…. Hauptthemen laut MEDLINE: Osteopontin, HLA-G Antigens, Proteomics, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, National Key Clinical Specialty Discipline Construction Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although programmed cell death protein 1 (PD-1) inhibitors combined with chemotherapy have improved outcomes in high-risk choriocarcinoma, primary resistance remains a clinically important challenge without reliable predictive biomarkers.

Methods

We performed data-independent acquisition mass spectrometry (DIA-MS) on pretreatment plasma from a nested discovery subset of 30 patients, followed by enzyme-linked immunosorbent assay (ELISA) assessment of shortlisted candidates in the full cohort of 60 patients. An exploratory two-marker logistic model was developed and internally assessed in the same cohort. Exploratory tissue immunophenotyping and analyses of public tissue-transcriptomic and immunotherapy datasets were used to provide biological context.

Results

DIA-MS identified a resistance-associated plasma proteomic signature enriched in inflammatory and immunomodulatory mediators among patients with progressive disease. In the full-cohort ELISA assessment, elevated baseline plasma HLA-G and osteopontin (OPN) were associated with primary resistance. The exploratory two-marker model showed an apparent area under the receiver operating characteristic curve of 0.908. In the limited tissue subset, higher HLA-G expression tended to be associated with lower CD8-positive T-cell density, whereas higher OPN expression was associated with increased CD163-positive macrophage density. Public-dataset analyses provided supportive context for associations of HLA-G and SPP1 transcript expression with immune-related programs and unfavorable outcomes.

Discussion

Elevated circulating HLA-G and OPN are associated with resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma and may serve as candidate minimally invasive biomarkers for pretreatment risk stratification. Independent validation and functional investigation are required before clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopontinHLA-G AntigensProteomicsBiomarkers, TumorDrug Resistance, NeoplasmChoriocarcinomaImmune Checkpoint InhibitorsUterine NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleProgrammed Cell Death 1 ReceptorAdultPregnancy

Stichwörter der Autor:innen

HLA-GPD-1 inhibitorchoriocarcinomagestational trophoblastic neoplasiaosteopontinplasma proteomics

Substanzen

OsteopontinHLA-G AntigensBiomarkers, TumorImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorSPP1 protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • National Clinical Research Center for Women's Health and Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking U…

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • National Key Clinical Specialty Discipline Construction Program of China

Zitieren

APA

Wang, W., Chen, T., Wang, H., Zhao, J., Yang, C., Wu, Y., Kong, Y., Wang, D., Li, Y., Yang, J., & Xiang, Y. (2026). Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1817862

Vancouver

Wang W, Chen T, Wang H, Zhao J, Yang C, Wu Y, et al. Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1817862

BibTeX
@article{Wang2026,
  author = {Wang, Weidi and Chen, Tianyi and Wang, Haoyu and Zhao, Jiayuan and Yang, Chen and Wu, Yuxiao and Kong, Yujia and Wang, Dan and Li, Yuan and Yang, Junjun and Xiang, Yang},
  title = {Integrated plasma proteomics identifies HLA-G and osteopontin as circulating biomarkers of resistance to PD-1 inhibitor plus chemotherapy in choriocarcinoma},
  journal = {Frontiers in Immunology},
  year = {2026},
  doi = {10.3389/fimmu.2026.1817862}
}
Kostenlos starten →